Researchers have developed a chemical tag that can detect and measure protein clumping, which is thought to contribute to neurodegenerative…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Deep brain stimulation (DBS) directed at the central part of the subthalamic nucleus (STN), a brain region important for…
Researchers have developed a method to detect clumps of alpha-synuclein protein, a hallmark of Parkinson’s disease, within extracellular vesicles…
The frequency of headaches, including tension-type headaches and migraines, is similar among people with and without Parkinson’s disease, according…
Two studies support the safety and tolerability of Nuplazid (pimavanserin) in older or frail adults with psychosis associated with…
Changes in the levels of thyroid hormones in the bloodstream are related to cognitive impairments in people with…
Nearly all people with Parkinson’s disease taking part in Medtronic‘s ADAPT-PD trial had symptom-related brain signals strong enough…
About 1 in 5 people with Parkinson’s disease in Italy have a family history of the disorder when the…
Scientists have discovered how to therapeutically target a class of molecular switches called GTPases that are involved in Parkinson’s…
Nearly 1 in 3 people in Japan with Parkinson’s disease also had sarcopenia, a progressive loss of muscle mass…